MB Financial Bank - Trust Department’s BioCryst Pharmaceuticals BCRX Stock Holding History

MB Financial Bank - Trust Department’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,225	Closed	-$15K	–	299
2016 Q1	$15K	Hold	5,225	–	–	﹤0.01%	263
2015 Q4	$54K	Hold	5,225	–	–	0.01%	217
2015 Q3	$60K	Hold	5,225	–	–	0.01%	229
2015 Q2	$78K	Hold	5,225	–	–	0.01%	217
2015 Q1	$47K	Buy	+5,225	New	+$54.1K	0.01%	274

Other funds holding BCRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

MB Financial Bank - Trust Department's BCRX Position: Q2 2016 in Review

MB Financial Bank - Trust Department sold out of BioCryst Pharmaceuticals (BCRX) in Q2 2016, closing a stake of 5,225 shares — an estimated $15K sold.

MB Financial Bank - Trust Department first reported a position in BCRX in Q1 2015 and held it in 5 quarters. The position peaked at $78K in Q2 2015. 100 funds tracked by Wall St. Rank hold BCRX as of Q2 2016.

MB Financial Bank - Trust Department reported no remaining BioCryst Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
MB Financial Bank - Trust Department sold 5,225 BioCryst Pharmaceuticals shares in Q2 2016, an estimated $15K.
MB Financial Bank - Trust Department first reported a position in BioCryst Pharmaceuticals in Q1 2015 and held it in 5 quarters.
MB Financial Bank - Trust Department's BioCryst Pharmaceuticals position peaked at $78K in Q2 2015.
100 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2016.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2016, filed 14 Jul 2016.